Skip to content

A study provides evidence that the drug azlocillin eliminates the bacteria that cause Lyme disease at the onset of infection in lab mice and cultures.

A study provides evidence that the drug azlocillin eliminates the bacteria that cause Lyme disease at the onset of infection in lab mice and cultures.

Published on

Most children with antibiotic-resistant urinary tract infections get better on less powerful antibiotics than lab tests say they need, says Stanford study.

Most children with antibiotic-resistant urinary tract infections get better on less powerful antibiotics than lab tests say they need, says Stanford study.

Published on

Patients who are taking the most common type of antidepressant may feel more pain when taking certain opioids, Stanford researchers have found.

Patients who are taking the most common type of antidepressant may feel more pain when taking certain opioids, Stanford researchers have found.

Stanford researchers have discovered a compound that reduces the symptoms of heart failure after a heart attack in initial animal tests.

Stanford researchers have discovered a compound that reduces the symptoms of heart failure after a heart attack in initial animal tests.

A Stanford professor unpacks some of the dynamics of the current drug pricing system and the potential effects of other approaches to this market.

A Stanford professor unpacks some of the dynamics of the current drug pricing system and the potential effects of other approaches to this market.

Stanford chemists have developed a potential new strategy for fighting antibiotic-resistant bacterium — adding a new molecule onto an existing antibiotic.

Stanford chemists have developed a potential new strategy for fighting antibiotic-resistant bacterium — adding a new molecule onto an existing antibiotic.

Published on

Stanford researchers have identified a small molecule that may help curb some of the symptoms of a genetic deficiency in glucose-6-phosphate dehydrogenase.

Stanford researchers have identified a small molecule that may help curb some of the symptoms of a genetic deficiency in glucose-6-phosphate dehydrogenase.

Published on

Decision scientist Mehlika Toy is working with the WHO to help eliminate the public health burden of hepatitis B by the year 2030.

Decision scientist Mehlika Toy is working with the WHO to help eliminate the public health burden of hepatitis B by the year 2030.

Low levels of a substance, acetyl-L-carnitine, in the blood are associated with depression. Could this "mood mirror" be a cure for the blues?

Low levels of a substance, acetyl-L-carnitine, in the blood are associated with depression. Could this "mood mirror" be a cure for the blues?